TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Adverse Neurogenic Actions of Dietary Salt
Brief Summary: Excess dietary salt increases the risk for cardiovascular events, even in people that are not hypertensive. There is some evidence that excess dietary salt exaggerates blood pressure and sympathetic nervous system responses to various perturbations and increases blood pressure variability. This proposal will examine the effects of low, medium, and high salt diets on cardiovascular reactivity and blood pressure variability.


Options:
A: Arm Label: Blood Pressure Reactivity; Type: EXPERIMENTAL; Interventions: Other: Low Sodium Diet, Other: Medium Sodium Diet, Other: High Sodium Diet | Arm Label: Blood Pressure Variability; Type: EXPERIMENTAL; Interventions: Other: Low Sodium Diet, Other: Medium Sodium Diet, Other: High Sodium Diet | Intervention Type: OTHER; Name: Low Sodium Diet; Assigned to Arm(s): Blood Pressure Reactivity, Blood Pressure Variability | Intervention Type: OTHER; Name: Medium Sodium Diet; Assigned to Arm(s): Blood Pressure Reactivity, Blood Pressure Variability | Intervention Type: OTHER; Name: High Sodium Diet; Assigned to Arm(s): Blood Pressure Reactivity, Blood Pressure Variability
B: Arm Label: Baseline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Acetylcholine (ACh) Dose Response, Drug: Local Heating (LH), Drug: Flow Mediated Dilation with nitroglycerin | Arm Label: Low Sodium, No Cheese; Type: EXPERIMENTAL; Interventions: Drug: Acetylcholine (ACh) Dose Response, Drug: Local Heating (LH), Drug: Flow Mediated Dilation with nitroglycerin | Arm Label: Low Sodium, Cheese; Type: EXPERIMENTAL; Interventions: Drug: Acetylcholine (ACh) Dose Response, Drug: Local Heating (LH), Drug: Flow Mediated Dilation with nitroglycerin | Arm Label: High Sodium, No Cheese; Type: EXPERIMENTAL; Interventions: Drug: Acetylcholine (ACh) Dose Response, Drug: Local Heating (LH), Drug: Flow Mediated Dilation with nitroglycerin | Arm Label: High Sodium, Cheese; Type: EXPERIMENTAL; Interventions: Drug: Acetylcholine (ACh) Dose Response, Drug: Local Heating (LH), Drug: Flow Mediated Dilation with nitroglycerin | Intervention Type: DRUG; Name: Acetylcholine (ACh) Dose Response; Assigned to Arm(s): Baseline, High Sodium, Cheese, High Sodium, No Cheese, Low Sodium, Cheese, Low Sodium, No Cheese | Intervention Type: DRUG; Name: Local Heating (LH); Assigned to Arm(s): Baseline, High Sodium, Cheese, High Sodium, No Cheese, Low Sodium, Cheese, Low Sodium, No Cheese | Intervention Type: DRUG; Name: Flow Mediated Dilation with nitroglycerin; Assigned to Arm(s): Baseline, High Sodium, Cheese, High Sodium, No Cheese, Low Sodium, Cheese, Low Sodium, No Cheese
C: Intervention Type: BEHAVIORAL; Name: Low Salt Diet versus High salt diet; Assigned to Arm(s): N/A
D: Arm Label: Control; Type: OTHER; Interventions: Other: Control | Arm Label: Salt reduction; Type: EXPERIMENTAL; Interventions: Behavioral: Salt reduction | Intervention Type: BEHAVIORAL; Name: Salt reduction; Assigned to Arm(s): Salt reduction | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Text Messaging on Risk Factors Control and Medication Adherence Among Patients With Coronary Heart Disease and Diabetes in China: Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study
Brief Summary: The study is a two-arm, parallel, randomized clinical trial. The purpose of the study is to evaluate the effectiveness of automated mobile phone text message-based intervention for secondary prevention, including lifestyles modification, medication adherence improvement and risk factors control among coronary heart disease (CHD) patients with diabetes. The participants will be randomized into intervention and control groups in a 1:1 ratio. The intervention group will receive 6 pre-designed text messages per week in addition to usual care for 6 months, while the control group will receive usual care.


Options:
A: Arm Label: Intervention-Text messaging; Type: EXPERIMENTAL; Interventions: Behavioral: Text messaging | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text messaging; Assigned to Arm(s): Intervention-Text messaging
B: Arm Label: Intervention SMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intervention SMS | Arm Label: Control SMS; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control SMS | Intervention Type: BEHAVIORAL; Name: Intervention SMS; Assigned to Arm(s): Intervention SMS | Intervention Type: BEHAVIORAL; Name: Control SMS; Assigned to Arm(s): Control SMS
C: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone text message | Arm Label: No Intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mobile phone text message; Assigned to Arm(s): Experimental
D: Arm Label: Mobile App Group; Type: EXPERIMENTAL; Interventions: Other: Daily reminders of taking medications, Other: Educational materials | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Educational materials | Intervention Type: OTHER; Name: Daily reminders of taking medications; Assigned to Arm(s): Mobile App Group | Intervention Type: OTHER; Name: Educational materials; Assigned to Arm(s): Control Group, Mobile App Group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multi-center, Randomized Non-inferiority Trial of Early Treatment Versus Expectative Management of Patent Ductus Arteriosus in Preterm Infants (BeNeDuctus Trial - Belgium Netherlands Ductus Trial)
Brief Summary: Much controversy exists about the optimal management of a patent ductus arteriosus (PDA) in preterm infants, especially in those born at a gestational age \<28 weeks and/or a birth weight ≦1000 grams due to a lack of evidence for or against different approaches. A PDA has been associated with serious complications. However, a common finding is that medical and/or surgical treatment of a PDA seems not to reduce the risk of mortality or major morbidity. This might be related to the fact that a substantial portion of preterm infants are treated unnecessarily, because the ductus arteriosus (DA) might have closed spontaneously without any specific intervention. An expectative approach is gaining interest, although convincing evidence is still missing.

The objective of this study is to investigate whether in preterm infants \<28 weeks' gestation with a PDA an expectative management is not inferior to early treatment with regard to the composite of mortality and/or necrotizing enterocolitis (NEC) and/or bronchopulmonary dysplasia (BPD) at a postmenstrual age of 36 weeks.


Options:
A: Arm Label: Early Treatment with cyclooxygenase inhibitors; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ibuprofen, Drug: Indomethacin | Arm Label: Expectative Treatment; Type: SHAM_COMPARATOR; Interventions: Other: Expectative Management | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): Early Treatment with cyclooxygenase inhibitors | Intervention Type: OTHER; Name: Expectative Management; Assigned to Arm(s): Expectative Treatment | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): Early Treatment with cyclooxygenase inhibitors
B: Arm Label: Oral paracetamol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oral paracetamol | Arm Label: Oral ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oral ibuprofen | Intervention Type: DRUG; Name: Oral paracetamol; Assigned to Arm(s): Oral paracetamol | Intervention Type: DRUG; Name: Oral ibuprofen; Assigned to Arm(s): Oral ibuprofen
C: Arm Label: early ibuprofen; Type: EXPERIMENTAL; Interventions: Drug: Early ibuprofen | Arm Label: Late Ibuprofen expectant group (placebo); Type: OTHER; Interventions: Other: Late ibuprofen expectant group (placebo) | Intervention Type: DRUG; Name: Early ibuprofen; Assigned to Arm(s): early ibuprofen | Intervention Type: OTHER; Name: Late ibuprofen expectant group (placebo); Assigned to Arm(s): Late Ibuprofen expectant group (placebo)
D: Arm Label: Paracetamol; Type: EXPERIMENTAL; Interventions: Drug: Paracetamol | Arm Label: Ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ibuprofen | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Paracetamol | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): Ibuprofen

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis
Brief Summary: This study evaluates the effectiveness of a web-based fall prevention program called Free From Falls Online (FFFO) on people with multiple sclerosis.


Options:
A: Arm Label: Home-based Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based exercise | Arm Label: Education; Type: EXPERIMENTAL; Interventions: Behavioral: Education | Arm Label: Exercise plus education; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise plus Education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home-based exercise; Assigned to Arm(s): Home-based Exercise | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education | Intervention Type: BEHAVIORAL; Name: Exercise plus Education; Assigned to Arm(s): Exercise plus education
B: Arm Label: Training group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Assistive Device Training | Arm Label: Wait-list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Assistive Device Training; Assigned to Arm(s): Training group
C: Arm Label: Free From Falls; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Free From Falls Online | Arm Label: Waitlist; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Waitlist Control | Intervention Type: BEHAVIORAL; Name: Free From Falls Online; Assigned to Arm(s): Free From Falls | Intervention Type: BEHAVIORAL; Name: Waitlist Control; Assigned to Arm(s): Waitlist
D: Arm Label: Group balance training early start; Type: EXPERIMENTAL; Interventions: Other: Group balance training | Arm Label: Group balance training late start; Type: EXPERIMENTAL; Interventions: Other: Group balance training | Intervention Type: OTHER; Name: Group balance training; Assigned to Arm(s): Group balance training early start, Group balance training late start

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction With Hypertonic Saline in Patient With Moderately Severe or Severe Symptomatic Severe Hyponatremia (SALSA Trial)
Brief Summary: This study will investigate efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patient with moderately severe or severe symptomatic severe hyponatremia


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Spironolactone and furosemide | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: Spironolactone and furosemide | Intervention Type: DRUG; Name: Spironolactone and furosemide; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Spironolactone and furosemide; Assigned to Arm(s): A, B
B: Intervention Type: DRUG; Name: SR121463B; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: satavaptan (SR121463B); Assigned to Arm(s): N/A
D: Arm Label: Intermittent bolus group; Type: ACTIVE_COMPARATOR; Interventions: Drug: 3% hypertonic saline | Arm Label: slow continuous infusion group; Type: ACTIVE_COMPARATOR; Interventions: Drug: 3% hypertonic saline | Intervention Type: DRUG; Name: 3% hypertonic saline; Assigned to Arm(s): Intermittent bolus group, slow continuous infusion group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Bipolar Illness Onset Study (the BIO Study)
Brief Summary: This longitudinal study aims to identify 1) a composite blood-based biomarker, 2) a composite electronic Smartphone-based biomarker and 3) a neurocognitive signature for bipolar disorder


Options:
A: Arm Label: Patients with bipolar disorder; Type: N/A; Interventions: N/A | Arm Label: Healthy first generation relatives; Type: N/A; Interventions: N/A | Arm Label: Healthy individuals; Type: N/A; Interventions: N/A
B: Arm Label: Ketamine, Then Placebo; Type: EXPERIMENTAL; Interventions: Drug: Ketamine, Drug: Placebo | Arm Label: Placebo, Then Ketamine; Type: EXPERIMENTAL; Interventions: Drug: Ketamine, Drug: Placebo | Intervention Type: DRUG; Name: Ketamine; Assigned to Arm(s): Ketamine, Then Placebo, Placebo, Then Ketamine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Ketamine, Then Placebo, Placebo, Then Ketamine
C: Arm Label: Aspirin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin | Arm Label: N-acetyl-cysteine; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: N-acetyl-cysteine (NAC) | Arm Label: Aspirin and NAC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin, Dietary Supplement: N-acetyl-cysteine (NAC) | Arm Label: Sugar Pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sugar Pill | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): Aspirin, Aspirin and NAC | Intervention Type: DIETARY_SUPPLEMENT; Name: N-acetyl-cysteine (NAC); Assigned to Arm(s): Aspirin and NAC, N-acetyl-cysteine | Intervention Type: DRUG; Name: Sugar Pill; Assigned to Arm(s): Sugar Pill
D: Arm Label: AXS-05; Type: EXPERIMENTAL; Interventions: Drug: AXS-05 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: AXS-05; Assigned to Arm(s): AXS-05 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Text Messaging on Risk Factors Control and Medication Adherence Among Coronary Heart Disease Patients Without Diabetes in Cardiovascular Health and Texting Messaging (CHAT) Study
Brief Summary: The study is a two-arm, parallel, randomized clinical trial. The purpose of the study is to evaluate the effectiveness of automated mobile phone text message-based intervention for secondary prevention, including lifestyles modification, medication adherence improvement and risk factors control among coronary heart disease (CHD) patients without diabetes. The participants will be randomized into intervention and control groups in a 1:1 ratio. The intervention group will receive 6 pre-designed text messages per week in addition to usual care for 6 months, while the control group will receive usual care.


Options:
A: Arm Label: Medication text message; Type: EXPERIMENTAL; Interventions: Behavioral: Text message reminder for medication adherence | Arm Label: Exercise text message; Type: EXPERIMENTAL; Interventions: Behavioral: Text message reminder for exercise regimen | Arm Label: Usual care, medication adherence; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Usual care, exercise regimen; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text message reminder for medication adherence; Assigned to Arm(s): Medication text message | Intervention Type: BEHAVIORAL; Name: Text message reminder for exercise regimen; Assigned to Arm(s): Exercise text message
B: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone text message | Arm Label: No Intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mobile phone text message; Assigned to Arm(s): Experimental
C: Arm Label: Intervention-Text messaging; Type: EXPERIMENTAL; Interventions: Behavioral: Text Messaging | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text Messaging; Assigned to Arm(s): Intervention-Text messaging
D: Arm Label: Intervention-Text messaging; Type: EXPERIMENTAL; Interventions: Behavioral: Text messaging | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text messaging; Assigned to Arm(s): Intervention-Text messaging

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Go NAP SACC: A Pilot Study Evaluating the Nutrition Tool of the Web-based Tool Based on the NAP SACC Program
Brief Summary: The purpose of this project is to evaluate the effectiveness of Go NAP SACC (Get online with Nutrition and Physical Activity Self-Assessment for Child Care), a suite of web-based tools designed to help child care programs improve their nutrition environment (specifically classrooms serving 3-5 year olds) over the course of 4 months.


Options:
A: Arm Label: CHild Inhibitory Control Play (CHIC) Play; Type: EXPERIMENTAL; Interventions: Behavioral: CHild Inhibitory Control (CHIC) Play | Arm Label: Attention control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention control | Intervention Type: BEHAVIORAL; Name: CHild Inhibitory Control (CHIC) Play; Assigned to Arm(s): CHild Inhibitory Control Play (CHIC) Play | Intervention Type: BEHAVIORAL; Name: Attention control; Assigned to Arm(s): Attention control
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Food and Physical Activity Environments | Arm Label: Comparison; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Comparison Group | Intervention Type: BEHAVIORAL; Name: Healthy Food and Physical Activity Environments; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Comparison Group; Assigned to Arm(s): Comparison
C: Arm Label: Center-based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Center-based Intervention | Arm Label: Center-and-home-based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based Intervention | Arm Label: Active Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Control | Intervention Type: BEHAVIORAL; Name: Center-based Intervention; Assigned to Arm(s): Center-based intervention | Intervention Type: BEHAVIORAL; Name: Home-based Intervention; Assigned to Arm(s): Center-and-home-based intervention | Intervention Type: BEHAVIORAL; Name: Active Control; Assigned to Arm(s): Active Control
D: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Go NAP SACC | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Go NAP SACC; Assigned to Arm(s): Intervention group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Go NAP SACC: A Pilot Study Evaluating the Nutrition Tool of the Web-based Tool Based on the NAP SACC Program
Brief Summary: The purpose of this project is to evaluate the effectiveness of Go NAP SACC (Get online with Nutrition and Physical Activity Self-Assessment for Child Care), a suite of web-based tools designed to help child care programs improve their nutrition environment (specifically classrooms serving 3-5 year olds) over the course of 4 months.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Go NAP SACC | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Go NAP SACC; Assigned to Arm(s): Intervention group
B: Arm Label: Experimental: Phase 1 Usual Exposure; Type: EXPERIMENTAL; Interventions: Behavioral: Usual Exposure | Arm Label: Experimental: Phase 1 Mealtime support activities; Type: EXPERIMENTAL; Interventions: Behavioral: Mealtime Supports | Arm Label: Experimental: Phase 2- Usual Exposure; Type: EXPERIMENTAL; Interventions: Behavioral: Usual Exposure | Arm Label: Experimental: Phase 2- Meal Delivery and Receipt of Cookware; Type: EXPERIMENTAL; Interventions: Behavioral: Mealtime Supports | Intervention Type: BEHAVIORAL; Name: Mealtime Supports; Assigned to Arm(s): Experimental: Phase 1 Mealtime support activities, Experimental: Phase 2- Meal Delivery and Receipt of Cookware | Intervention Type: BEHAVIORAL; Name: Usual Exposure; Assigned to Arm(s): Experimental: Phase 1 Usual Exposure, Experimental: Phase 2- Usual Exposure
C: Arm Label: Comparison Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Parenting Program; Type: EXPERIMENTAL; Interventions: Behavioral: Parenting Program | Intervention Type: BEHAVIORAL; Name: Parenting Program; Assigned to Arm(s): Parenting Program
D: Arm Label: Immediate Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Eating and Physical Activity | Arm Label: Delayed Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Eating and Physical Activity | Intervention Type: BEHAVIORAL; Name: Healthy Eating and Physical Activity; Assigned to Arm(s): Delayed Intervention, Immediate Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Go NAP SACC: A Pilot Study Evaluating the Nutrition Tool of the Web-based Tool Based on the NAP SACC Program
Brief Summary: The purpose of this project is to evaluate the effectiveness of Go NAP SACC (Get online with Nutrition and Physical Activity Self-Assessment for Child Care), a suite of web-based tools designed to help child care programs improve their nutrition environment (specifically classrooms serving 3-5 year olds) over the course of 4 months.


Options:
A: Arm Label: Program SI! educational intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Program SI! educational intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Program SI! educational intervention; Assigned to Arm(s): Program SI! educational intervention
B: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Go NAP SACC | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Go NAP SACC; Assigned to Arm(s): Intervention group
C: Arm Label: Train-the-Trainers Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Caregivers- Healthy Children Toolkit | Arm Label: Attention Control Arm; Type: OTHER; Interventions: Behavioral: Safety Curriculum | Intervention Type: BEHAVIORAL; Name: Healthy Caregivers- Healthy Children Toolkit; Assigned to Arm(s): Train-the-Trainers Arm | Intervention Type: BEHAVIORAL; Name: Safety Curriculum; Assigned to Arm(s): Attention Control Arm
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Parents Connect for Healthy Living (PConnect), Behavioral: Enhanced Nutrition Support, Behavioral: Media Resources | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Parents Connect for Healthy Living (PConnect); Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Nutrition Support; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Media Resources; Assigned to Arm(s): Intervention

Answer: B